RecruitingNCT06772493

ViewFlex X ICE First-in-Human Study

Sponsor

Abbott Medical Devices

Enrollment

500 participants

Start Date

Dec 16, 2024

Study Type

OBSERVATIONAL

Conditions

Cardiac Arrhythmias

Summary

This prospective, acute, first-in-human, non-significant risk study is intended to evaluate a modified version of the ViewFlex X ICE Catheter, Sensor Enabled (ViewFlex X SE) and ViewMate Multi Ultrasound Console (VMM) ICE data integration with the EnSite X EP System (hereafter referred to as the ViewFlex X ICE System).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called ViewFlex X ICE System for people with cardiac arrhythmias. The study is currently recruiting participants at 8 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEViewFlex X ICE System

Subjects to undergo cardiac ablation procedure utilizing the ViewFlex X ICE System

Locations(8)

St. Bernards Medical Center

Jonesboro, Arkansas, United States

University of California, San Diego

La Jolla, California, United States

Ascension St. Vincent's Riverside

Jacksonville, Florida, United States

Research Medical Center

Kansas City, Missouri, United States

NYU Langone Health

New York, New York, United States

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

Medical University of South Carolina

Charleston, South Carolina, United States

Houston Methodist Hospital

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06772493

Related Trials

Bad Berka Heart Rhythm Registry of Patients With or at Risk of Arrhythmias Treated at Heart Center Bad Berka

NCT070209101 location

Predict Arrhythmia Risk Using Intelligent Software

NCT07792694

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

NCT057241211 location

AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)

NCT0589071613 locations

The Clinical Outcomes and Therapeutic Effects in Patients With Cardiac Implantable Electronic Device-detected Subclinical and Clinical Atrial Fibrillation.

NCT076491091 location